Introduction
Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by abnormal sickle hemoglobin (HbS) production, hemolytic anemia, and intermittent occlusion of small blood vessels, leading to acute and chronic tissue ischemia, chronic organ damage, and organ dysfunction including endocrine organs [1] . HbS is common and clinically significant structural hemoglobin variant [2] .
HbS is caused by a mutation in the b-globin gene in which the 17th nucleotide is changed from thymine to adenine and the sixth amino acid in b-globin chain is changed to valine instead of glutamic acid; this mutation produces hydrophobic motif in the deoxygenated HbS tetramer that results in binding between b1 and b2 chains of two hemoglobin molecules. This crystallization produces a polymer nucleus, which grows and fills the erythrocyte, disrupting its architecture and flexibility and promoting cellular dehydration, with physical and oxidative cellular stress [3] .
Endocrine dysfunction is commonly encountered in hematological diseases like thalassemia and SCD. The physiopathology of endocrine organ pathology is not clear in patients with SCD; however, iron storage due to recurrent and frequent transfusions, or ischemia due to vasoocclusive crises and inflammatory mediators during ischemia are proposed as the main reasons for endocrine dysfunctions [4] .
The prevalence of endocrine complications among children with sickle-cell anemia (HbSS) varies in different populations depending on the literacy rate, socioeconomic status, availability of regular chelation therapy, and transfusions [5] .
Gonadal iron deposition and gonadal damage due to iron overload is an irreversible process even if the iron level is corrected at a later stage of the SCD [6] . This reflects the importance of early and regular use of iron chelators for prevention of irreversible damage of the ovaries and attaining normal sexual maturation and the necessity of regular follow up for gonadal hormones with assessment of puberty as females with thalassemia and SCA are more vulnerable to develop hypogonadism and may be in need of hormonal replacement therapy to be capable of achieving pregnancy [7] . The aim of this work was to evaluate some gonadal functions in females with HbSS.
Material and methods
This study was done after the approval from the Ethical Committee of the Research Center of Tanta University, Tanta, Egypt and parental consent was received for all children included in this study. The study was carried out on 40 females with HbSS who were attendants at the Hematology Unit, Pediatric Department, Tanta University in the period from May 2012 to April 2014, whose ages ranged from 11 years to 15 years and the mean age value was 12.63 ± 1.36 years (Group I), and 40 female children with HbSS with ages ranging from 11 years to 15 years and with a mean age value of 12.22 ± 1.13 years with no iron overload as a control group (Group II).
This study included females with HbSS with serum ferritin of >1000 ng/mL (with iron overload) that came to our Hematology Center within a 2-year period of the study (40 female patients).
Females with HbSS under hormonal therapy were excluded from this study.
All patient and control Groups were subjected to the following: (a) complete history taking; (b) thorough clinical examination with special attention to anthropometric measurements including weight and height, pallor, jaundice, splenomegaly, hepatomegaly, and Tanner staging for assessment of puberty [8] ; and (c) laboratory investigations.
Specimen collection and handling
Five milliliters of venous blood were collected using sterile needles through gentle venipuncture after sterilization of the puncture site with alcohol, and collected samples were divided into: (a) 2 mL in 20 lL ethylenediaminetetraacetic acid solution for complete blood count including differential white blood cells count which was done on a Leishman stained peripheral blood smear with evaluation using an ERMA PCE-210 N cell counter (fully automated blood cells counter from ERMA. Inc., Japan) [9] , hemoglobin electrophoresis [10] , and (b) 3 mL in a plain tube that allowed for clotting in a water bath at 37°C. After clotting, centrifugation was done at 1500g for 10 min. Separated serum was collected in three tubes. The first tube was for assessment of serum iron and iron binding capacity, the second tube for assessment of serum ferritin, and the third for assessment of FSH, LH, and estrogen serum levels [11] [12] [13] [14] [15] [16] .
Chelation therapy
All patients were treated with deferasirox, 20-30 mg/kg/d once daily, preferably before meals [17] , but in patients with persistently high serum ferritin levels above 3000 ng/ mL, deferasirox was combined with desferrioxamine, 20-40 mg/kg in 8-12 h subcutaneous infusion using an infusion pump [17] or continuous intravenous infusion for 8-10 h per day for 10 days per month [18] .
Statistical analysis
Statistical analysis of the present study was conducted using mean, standard error, Student t test, chi-square test, linear correlation coefficient test with SPSS version 17 (SPSS Inc., Chicago, IL, USA).
Results
There were no statistically significant differences between Groups I and II with regards to age and clinical presentation including pallor, jaundice, hepatomegaly, acute chest syndrome, and sickle cell crisis, but there were significant differences between Groups I and II regarding transfusion regimen (Table 1) .
There were normocytic normochromic anemia with reticulocytosis, leukocytosis, and thrombocytosis in studied patients of HbSS of both groups with no statistically significant differences between Groups I and II regarding hemoglobin level, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, reticulocytes, platelets, and white blood cell counts (Table 2) .
There were significant differences regarding tanner staging with delayed puberty according to tanner staging in Group I compared with Group II (Table 3) .
There were significantly higher serum ferritin and serum iron and significantly lower total iron binding capacity, FSH, LH, and estrogen levels in Group I compared with Group II (mean serum ferritin was 2635. Table 4 ).
There were significant negative correlations between serum FSH, LH, estrogen, and serum ferritin ( Figures. 1-3 ). In this study iron overload was found to be a significant cause of hypogonadism in Group I using univariate analysis (see Table 5 ). 
Discussion
SCD is an inherited disorder, characterized by defective hemoglobin synthesis with production of HbS. Red blood cells that contain HbS become deformed, rigid with loss of ability to pass through narrow capillaries leading to frequent thrombosis, vascular occlusions, and progressive organ damage [1] . The aim of this study was to assess serum levels of some gonadal hormones in 40 female children with HbSS in correlation with iron overload.
In this study, there was significantly higher serum ferritin and iron levels and significantly lower total iron binding capacity in Group I compared with Group II. This is in agreement with Akodu et al. [19] and Akinsegun et al. [20] who found that chronic hemolysis and repeated blood transfusion are the main causes of iron overload in patients with chronic hemolytic anemia as with the regular blood transfusion, the equivalent of 100-200 mL of pure red blood cells per kg per year are transfused, which is equivalent to 108-216 mg of iron per kg body weight per year. Thus, with regular blood transfusion, iron stores increase to many times the normal unless regular chelation therapy is given [21] .
In the current study, there was delayed puberty in Group I compared with Group II with regards to Tanner staging. This is in agreement with Thomas et al. [22] who stated that puberty is delayed for about 2 years in boys and girls with SCA. Serjeant et al. [23] who studied 99 patients with homozygous SCA, 69 with sickle cell hemoglobin C disease, and 100 controls with normal hemoglobin genotypes, and found a delayed mean age of menarche by 0.5 years in sickle cell hemoglobin C disease and by 2.4 years in homozygous HbSS. Kyriakou and Skordis [24] stated that hypothalamus and pituitary damage is progressive in patients with HbSS with iron overload, even when intensive iron chelation therapy was given and hypogonadism is often unavoidable.
Hypogonadotrophic hypogonadism could be explained iron toxicity on gonadotroph cells and adipose tissue, with resulting impaired synthesis of leptin and a decrease in the physiological role of leptin in sexual maturation and fertility, as leptin levels increase dramatically in early puberty and stimulate the hypothalamic-pituitary-gonadal axis [25] . Other possible causes of hypogonadotrophic hypogonadism may include liver disorders, chronic hypoxia, diabetes mellitus, and zinc deficiency [26] . Our study showed that iron overload was a significant cause of hypogonadism in Group I using univariate analysis.
In the current study, serum levels of LH, FSH, and estrogen were significantly lower in Group I compared with Group II. This is in agreement with Wood et al. [27] , Kurtoglu et al. [28] and Abdulzahra et al. [29] who explained different endocrine problems in HbSS patients with iron overload by iron deposition in secretory cell of endocrine glands such Figure 1 Correlation between serum ferritin and serum follicle-stimulating hormone. There was significant negative correlations between serum ferritin and serum follicle-stimulating hormone in the studied patients. Note. FSH = folliclestimulating hormone. Figure 2 Correlation between serum ferritin and serum luteinizing hormone. There were significant negative correlations between serum ferritin and serum luteinizing hormone in the studied patients. Note. LH = luteinizing hormone. Figure 3 Correlation between serum ferritin and serum estrogen. There were significant negative correlations between serum ferritin and serum estrogen in the studied patients.
as gonadotrophin cell of the pituitary gland that leads to the impairment of gonadal hormone secretion including FSH and LH [27] [28] [29] . Also, the ovaries are vulnerable to the toxic effect of excess iron even if it is not persistent leading to deficiency of estrogen hormone secretion [26] .
In the current study, there were significant negative correlations between serum estrogen, LH, FSH, and serum ferritin levels. This is in agreement with Kyriakou and Skordis [24] . This could be explained by progressive damage of the pituitary gland with a subsequent decrease of gonadal hormones with a progressive increase in iron load.
Conclusion
Female patients with HbSS may have gonadal hormones deficiency with a significant negative correlation between gonadal hormones including FSH, LH, estrogen, and serum ferritin. Recommendations include: (1) regular iron chelation for the prevention of irreversible damage to the ovaries and attaining normal sexual maturation; and (2) regular follow up for females with HbSS with assessment of puberty, as they are more vulnerable to develop hypogonadism and may require hormonal replacement therapy.
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